Skip to Main Content

Paper Details

Long-term response to sintilimab, bevacizumab and chemotherapy in heavily pretreated microsatellite stable colon cancer.
0
2023
MSS, advanced colorectal cancer, bevacizumab, colon adenocarcinoma, colon cancer, metastatic colon adenocarcinoma, microsatellite stable colon cancer, patient, patients, sintilimab
Author NameAffiliation
Beifang NiuChinese Academy of Sciences
Beifang NiuChosenMed Technology (Beijing) Co.
Beifang NiuUniversity of the Chinese Academy of Sciences
  • 1 - 3

Datasets

Release 1.2